Identification Generic Name (1S)-1-Phenylethyl (4-acetamidobenzyl)phosphonate DrugBank Accession Number DB08545 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1S)-1-Phenylethyl (4-acetamidobenzyl)phosphonate (DB08545) ×  Close Weight Average: 332.3108  Monoisotopic: 332.105169613  Chemical Formula C 17 H 19 NO 4 P Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Hepatitis B virus receptor binding protein Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as acetanilides. These are organic compounds containing an acetamide group conjugated to a phenyl group. Kingdom Organic compounds Super Class Benzenoids Class Benzene and substituted derivatives Sub Class Anilides Direct Parent Acetanilides Alternative Parents N-acetylarylamines  /  Phosphonic acid esters  /  Organic phosphonic acids  /  Acetamides  /  Secondary carboxylic acid amides  /  Organophosphorus compounds  /  Organic oxides  /  Hydrocarbon derivatives  /  Carbonyl compounds  /  Organic anions Substituents Acetamide  /  Acetanilide  /  Aromatic homomonocyclic compound  /  Carbonyl group  /  Carboxamide group  /  Carboxylic acid derivative  /  Hydrocarbon derivative  /  N-acetylarylamine  /  N-arylamide  /  Organic anion Molecular Framework Aromatic homomonocyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key YPTMOJMDCPUCJT-ZDUSSCGKSA-M InChI InChI=1S/C17H20NO4P/c1-13(16-6-4-3-5-7-16)22-23(20,21)12-15-8-10-17(11-9-15)18-14(2)19/h3-11,13H,12H2,1-2H3,(H,18,19)(H,20,21)/p-1/t13-/m0/s1 IUPAC Name (1S)-1-phenylethyl [(4-acetamidophenyl)methyl]phosphonate SMILES [H]N(C(C)=O)C1=CC=C(CP([O-])(=O)O[C@@H](C)C2=CC=CC=C2)C=C1 References General References Not Available External Links PubChem Compound 131704310 PubChem Substance 99445016 ChemSpider 4451347 PDBe Ligand SH4 PDB Entries 1um4 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.0569 mg/mL ALOGPS logP 2.51 ALOGPS logP 2.56 Chemaxon logS -3.8 ALOGPS pKa (Strongest Acidic) 1.89 Chemaxon pKa (Strongest Basic) -4.4 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 78.46 Å 2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 89.17 m 3 ·mol -1 Chemaxon Polarizability 33.44 Å 3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.5118 Blood Brain Barrier + 0.9932 Caco-2 permeable + 0.5284 P-glycoprotein substrate Non-substrate 0.8221 P-glycoprotein inhibitor I Non-inhibitor 0.7429 P-glycoprotein inhibitor II Non-inhibitor 0.666 Renal organic cation transporter Non-inhibitor 0.9033 CYP450 2C9 substrate Non-substrate 0.7929 CYP450 2D6 substrate Non-substrate 0.7982 CYP450 3A4 substrate Substrate 0.6237 CYP450 1A2 substrate Non-inhibitor 0.6666 CYP450 2C9 inhibitor Inhibitor 0.6488 CYP450 2D6 inhibitor Non-inhibitor 0.9217 CYP450 2C19 inhibitor Inhibitor 0.508 CYP450 3A4 inhibitor Non-inhibitor 0.7344 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.7715 Ames test AMES toxic 0.6122 Carcinogenicity Non-carcinogens 0.5183 Biodegradation Not ready biodegradable 0.5294 Rat acute toxicity 2.7464 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9323 hERG inhibition (predictor II) Non-inhibitor 0.7662    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Hepatitis B virus receptor binding protein Kind Protein Organism Humans Pharmacological action Unknown General Function Not Available Specific Function Not Available Gene Name Not Available Uniprot ID Q6PYX1 Uniprot Name Hepatitis B virus receptor binding protein Molecular Weight 38161.965 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:32 / Updated at June 12, 2020 16:52 